Head to Head Survey: Lucira Health (LHDXQ) Versus The Competition
Head to Head Survey: Lucira Health (LHDXQ) Versus The Competition
Lucira Health (NASDAQ:LHDXQ – Get Rating) is one of 40 public companies in the "Diagnostic substances" industry, but how does it compare to its competitors? We will compare Lucira Health to related businesses based on the strength of its profitability, analyst recommendations, institutional ownership, earnings, valuation, dividends and risk.
Lucira Health（納斯達克股票代碼：LHDXQ — 獲取評級）是 “診斷物質” 行業的40家上市公司之一，但與競爭對手相比如何？我們將根據Lucira Health的盈利能力、分析師建議、機構所有權、收益、估值、股息和風險將其與相關業務進行比較。
Profitability
盈利能力
This table compares Lucira Health and its competitors' net margins, return on equity and return on assets.
該表比較了Lucira Health及其競爭對手的淨利潤率、股本回報率和資產回報率。
| Net Margins | Return on Equity | Return on Assets | |
| Lucira Health | -67.54% | -13.55% | -8.47% |
| Lucira Health Competitors | -802.63% | -114.55% | -27.76% |
| 淨利潤 | 股本回報率 | 資產回報率 | |
| 露西拉健康 | -67.54% | -13.55% | -8.47% |
| 露西拉健康競爭對手 | -802.63% | -114.55% | -27.76% |
Institutional and Insider Ownership
機構所有權和內部所有權
57.0% of Lucira Health shares are owned by institutional investors. Comparatively, 48.2% of shares of all "Diagnostic substances" companies are owned by institutional investors. 30.4% of Lucira Health shares are owned by insiders. Comparatively, 12.9% of shares of all "Diagnostic substances" companies are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.
Lucira Health的57.0％的股份由機構投資者持有。相比之下，所有 “診斷物質” 公司的48.2％的股份由機構投資者擁有。Lucira Health的股份中有30.4％由內部人士擁有。相比之下，所有 “診斷物質” 公司的12.9％的股份由內部人士擁有。強大的機構所有權表明對沖基金、捐贈基金和大型基金經理認爲一家公司有望實現長期增長。
Analyst Recommendations
分析師建議
This is a summary of recent recommendations and price targets for Lucira Health and its competitors, as provided by MarketBeat.
這是MarketBeat提供的Lucira Health及其競爭對手最近的建議和目標價格的摘要。
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Lucira Health | 0 | 0 | 0 | 0 | N/A |
| Lucira Health Competitors | 371 | 632 | 1236 | 19 | 2.40 |
| 賣出評級 | 持有評級 | 買入評級 | 強勁的買入評級 | 評分分數 | |
| 露西拉健康 | 0 | 0 | 0 | 0 | 不適用 |
| 露西拉健康競爭對手 | 371 | 632 | 1236 | 19 | 2.40 |
As a group, "Diagnostic substances" companies have a potential upside of 36.92%. Given Lucira Health's competitors higher probable upside, analysts clearly believe Lucira Health has less favorable growth aspects than its competitors.
作爲一個整體，“診斷物質” 公司的潛在上漲空間爲36.92％。鑑於Lucira Health的競爭對手可能有更高的上行空間，分析師顯然認爲Lucira Health的增長方面不如競爭對手。
Volatility & Risk
波動性與風險
Lucira Health has a beta of 3.36, indicating that its share price is 236% more volatile than the S&P 500. Comparatively, Lucira Health's competitors have a beta of 1.36, indicating that their average share price is 36% more volatile than the S&P 500.
Lucira Health的beta值爲3.36，這表明其股價的波動性比標準普爾500指數高236％。相比之下，Lucira Health的競爭對手的beta值爲1.36，這表明其平均股價的波動性比標準普爾500指數高36％。
Valuation and Earnings
估值和收益
This table compares Lucira Health and its competitors revenue, earnings per share (EPS) and valuation.
該表比較了Lucira Health及其競爭對手的收入、每股收益（EPS）和估值。
| Gross Revenue | Net Income | Price/Earnings Ratio | |
| Lucira Health | $93.06 million | -$64.83 million | -0.01 |
| Lucira Health Competitors | $480.44 million | $10.80 million | -55.18 |
| 總收入 | 淨收入 | 市盈率 | |
| 露西拉健康 | 9306 萬美元 | -6,483 萬美元 | -0.01 |
| 露西拉健康競爭對手 | 4.8044 億美元 | 1,080 萬美元 | -55.18 |
Lucira Health's competitors have higher revenue and earnings than Lucira Health. Lucira Health is trading at a higher price-to-earnings ratio than its competitors, indicating that it is currently more expensive than other companies in its industry.
Lucira Health的競爭對手的收入和收益高於Lucira Health。Lucira Health的交易市盈率高於競爭對手，這表明它目前比該行業的其他公司更昂貴。
Summary
摘要
Lucira Health beats its competitors on 7 of the 10 factors compared.
在比較的10個因素中，Lucira Health在7個因素上擊敗了競爭對手。
About Lucira Health
關於 Lucira Health
(Get Rating)
（獲取評級）
Lucira Health Inc. is a medical technology company. It is focused on the development and commercialization of transformative and infectious disease test kits. Lucira Health Inc. is based in Emeryville, California.
Lucira Health Inc. 是一家醫療技術公司。它專注於變革性和傳染病檢測試劑盒的開發和商業化。Lucira Health Inc. 總部位於加利福尼亞州的埃默裏維爾。
Receive News & Ratings for Lucira Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lucira Health and related companies with MarketBeat.com's FREE daily email newsletter.
接收 Lucira Health Daily 的新聞和評級 -在下面輸入您的電子郵件地址，即可通過Marketbeat.com的免費每日電子郵件時事通訊接收Lucira Health及相關公司的最新新聞和分析師評級的簡明每日摘要。
譯文內容由第三人軟體翻譯。